Cardiogenic shock. [Review]

MedStar author(s):
Citation: Cardiology Clinics. 31(4):567-80, viii, 2013 Nov.PMID: 24188221Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Shock, Cardiogenic/th [Therapy] | Assisted Circulation/mt [Methods] | Cardiovascular Agents/tu [Therapeutic Use] | Coronary Care Units | Extracorporeal Membrane Oxygenation | Heart Rupture, Post-Infarction/di [Diagnosis] | Heart Rupture, Post-Infarction/su [Surgery] | Heart-Assist Devices | Hemodynamics/ph [Physiology] | Humans | Myocardial Revascularization/mt [Methods] | Prognosis | Randomized Controlled Trials as Topic | Shock, Cardiogenic/di [Diagnosis] | Shock, Cardiogenic/et [Etiology] | Ventricular Dysfunction, Right/di [Diagnosis] | Ventricular Dysfunction, Right/th [Therapy]Local holdings: Available online from MWHC library: 1996 - present, Available in print through MWHC library: August 1998 - February 2004ISSN:
  • 0733-8651
Name of journal: Cardiology clinicsAbstract: Cardiogenic shock (CS) is a condition in which a marked reduction in cardiac output and inadequate end-organ perfusion results from an array of cardiac insults, the most common of which is acute myocardial infarction. CS is a systemic disease involving a vicious cycle of inflammation, ischemia, and progressive myocardial dysfunction, which often results in death. This life-threatening emergency requires intensive monitoring accompanied by aggressive hemodynamic support; other therapies are tailored to the specific pathophysiology. The development of novel therapeutic strategies is urgently required to reduce the unacceptably high mortality rates currently associated with CS. Copyright 2013 Elsevier Inc. All rights reserved.All authors: Cooper HA, Panza JADigital Object Identifier: Date added to catalog: 2014-08-21
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article Available 24188221

Available online from MWHC library: 1996 - present, Available in print through MWHC library: August 1998 - February 2004

Cardiogenic shock (CS) is a condition in which a marked reduction in cardiac output and inadequate end-organ perfusion results from an array of cardiac insults, the most common of which is acute myocardial infarction. CS is a systemic disease involving a vicious cycle of inflammation, ischemia, and progressive myocardial dysfunction, which often results in death. This life-threatening emergency requires intensive monitoring accompanied by aggressive hemodynamic support; other therapies are tailored to the specific pathophysiology. The development of novel therapeutic strategies is urgently required to reduce the unacceptably high mortality rates currently associated with CS. Copyright 2013 Elsevier Inc. All rights reserved.

English

Powered by Koha